Bank of New York Mellon’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $628M | Sell |
1,193,343
-311,189
| -21% | -$175M | 0.1% | 181 |
|
|
2026
Q1 | $845M | Sell |
1,504,532
-119,937
| -7% | -$76.9M | 0.16% | 126 |
|
|
2025
Q4 | $1.1B | Sell |
1,624,469
-432,211
| -21% | -$294M | 0.19% | 97 |
|
|
2025
Q3 | $1.31B | Buy |
2,056,680
+605,290
| +42% | +$367M | 0.24% | 79 |
|
|
2025
Q2 | $778M | Buy |
1,451,390
+884,808
| +156% | +$423M | 0.15% | 134 |
|
|
2025
Q1 | $238M | Sell |
566,582
-10,462
| -2% | -$4.54M | 0.05% | 324 |
|
|
2024
Q4 | $239M | Sell |
577,044
-20,619
| -3% | -$9.04M | 0.04% | 329 |
|
|
2024
Q3 | $302M | Sell |
597,663
-22,146
| -4% | -$10.8M | 0.06% | 286 |
|
|
2024
Q2 | $302M | Sell |
619,809
-12,179
| -2% | -$6.11M | 0.06% | 277 |
|
|
2024
Q1 | $341M | Sell |
631,988
-24,917
| -4% | -$13.6M | 0.07% | 261 |
|
|
2023
Q4 | $365M | Sell |
656,905
-4,466
| -0.7% | -$2.1M | 0.07% | 240 |
|
|
2023
Q3 | $289M | Sell |
661,371
-4,684
| -0.7% | -$2.34M | 0.06% | 279 |
|
|
2023
Q2 | $335M | Sell |
666,055
-7,407
| -1% | -$3.55M | 0.07% | 251 |
|
|
2023
Q1 | $337M | Sell |
673,462
-18,882
| -3% | -$9.04M | 0.07% | 252 |
|
|
2022
Q4 | $282M | Sell |
692,344
-3,981
| -0.6% | -$1.55M | 0.06% | 271 |
|
|
2022
Q3 | $227M | Sell |
696,325
-19,926
| -3% | -$7.32M | 0.06% | 320 |
|
|
2022
Q2 | $251M | Sell |
716,251
-23,741
| -3% | -$9.68M | 0.06% | 306 |
|
|
2022
Q1 | $405M | Sell |
739,992
-186,275
| -20% | -$98M | 0.08% | 229 |
|
|
2021
Q4 | $610M | Sell |
926,267
-17,725
| -2% | -$11.1M | 0.11% | 161 |
|
|
2021
Q3 | $587M | Buy |
943,992
+109,920
| +13% | +$73.9M | 0.11% | 157 |
|
|
2021
Q2 | $527M | Buy |
834,072
+96,356
| +13% | +$53.2M | 0.1% | 176 |
|
|
2021
Q1 | $361M | Buy |
737,716
+18,767
| +3% | +$9.4M | 0.07% | 242 |
|
|
2020
Q4 | $359M | Buy |
718,949
+3,268
| +0.5% | +$1.46M | 0.08% | 212 |
|
|
2020
Q3 | $281M | Buy |
715,681
+6,718
| +0.9% | +$2.48M | 0.07% | 237 |
|
|
2020
Q2 | $234M | Sell |
708,963
-17,871
| -2% | -$5.17M | 0.06% | 264 |
|
|
2020
Q1 | $176M | Buy |
726,834
+13,544
| +2% | +$3.53M | 0.06% | 292 |
|
|
2019
Q4 | $186M | Sell |
713,290
-9,266
| -1% | -$2.44M | 0.05% | 349 |
|
|
2019
Q3 | $196M | Sell |
722,556
-11,693
| -2% | -$3.25M | 0.05% | 320 |
|
|
2019
Q2 | $202M | Sell |
734,249
-35,500
| -5% | -$8.75M | 0.06% | 320 |
|
|
2019
Q1 | $172M | Buy |
769,749
+72,175
| +10% | +$14.9M | 0.05% | 365 |
|
|
2018
Q4 | $130M | Sell |
697,574
-384,952
| -36% | -$78.9M | 0.04% | 418 |
|
|
2018
Q3 | $270M | Sell |
1,082,526
-22,161
| -2% | -$5.38M | 0.07% | 267 |
|
|
2018
Q2 | $241M | Sell |
1,104,687
-31,074
| -3% | -$6.4M | 0.07% | 295 |
|
|
2018
Q1 | $217M | Sell |
1,135,761
-5,445
| -0.5% | -$1M | 0.06% | 326 |
|
|
2017
Q4 | $178M | Buy |
1,141,206
+185,981
| +19% | +$29.3M | 0.05% | 400 |
|
|
2017
Q3 | $149M | Buy |
955,225
+220,818
| +30% | +$34.9M | 0.04% | 434 |
|
|
2017
Q2 | $119M | Sell |
734,407
-132,970
| -15% | -$21.6M | 0.03% | 507 |
|
|
2017
Q1 | $134M | Sell |
867,377
-177,162
| -17% | -$24.4M | 0.04% | 470 |
|
|
2016
Q4 | $122M | Buy |
1,044,539
+28,726
| +3% | +$3.28M | 0.04% | 489 |
|
|
2016
Q3 | $115M | Sell |
1,015,813
-8,487
| -0.8% | -$894K | 0.03% | 487 |
|
|
2016
Q2 | $95.1M | Sell |
1,024,300
-14,752
| -1% | -$1.27M | 0.03% | 545 |
|
|
2016
Q1 | $81.4M | Buy |
1,039,052
+7,754
| +0.8% | +$558K | 0.02% | 642 |
|
|
2015
Q4 | $75.2M | Sell |
1,031,298
-36,427
| -3% | -$2.6M | 0.02% | 667 |
|
|
2015
Q3 | $79.3M | Sell |
1,067,725
-82,598
| -7% | -$5.92M | 0.02% | 634 |
|
|
2015
Q2 | $73.8M | Buy |
1,150,323
+45,745
| +4% | +$3.17M | 0.02% | 715 |
|
|
2015
Q1 | $85.3M | Buy |
1,104,578
+67,640
| +7% | +$5.26M | 0.02% | 659 |
|
|
2014
Q4 | $76.9M | Sell |
1,036,938
-75,976
| -7% | -$5.33M | 0.02% | 689 |
|
|
2014
Q3 | $65.6M | Sell |
1,112,914
-10,710
| -1% | -$677K | 0.02% | 744 |
|
|
2014
Q2 | $75M | Sell |
1,123,624
-7,322
| -0.6% | -$466K | 0.02% | 706 |
|
|
2014
Q1 | $68.6M | Buy |
1,130,946
+35,154
| +3% | +$2.09M | 0.02% | 731 |
|
|
2013
Q4 | $58.3M | Sell |
1,095,792
-56,870
| -5% | -$2.99M | 0.02% | 803 |
|
|
2013
Q3 | $57.4M | Sell |
1,152,662
-55,818
| -5% | -$2.68M | 0.02% | 788 |
|
|
2013
Q2 | $54.2M | Buy |
+1,208,480
| New | +$52.8M | 0.02% | 779 |
|
Other funds holding IDXX
N
MBI
Bank of New York Mellon's IDXX Position: Q2 2026 in Review
Bank of New York Mellon reduced its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, selling an estimated $175M and leaving 1,193,343 shares worth $628M. The position accounts for 0.1% of the portfolio, ranked #181.
Bank of New York Mellon first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.31B in Q3 2025. 796 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Bank of New York Mellon held 1,193,343 shares of Idexx Laboratories worth $628M as of Q2 2026.
- Bank of New York Mellon sold 311,189 Idexx Laboratories shares in Q2 2026, an estimated $175M.
- Idexx Laboratories made up 0.1% of Bank of New York Mellon's portfolio in Q2 2026, its #181 holding.
- Bank of New York Mellon first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Idexx Laboratories position peaked at $1.31B in Q3 2025.
- 796 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.